For the first time, people who want to stop using crystal methamphetamine may be able to treat their addiction with a cheap and readily available medication, say researchers at the National Drug and Alcohol Research Center (NDARC), UNSW Sydney. Results from the landmark Tina Trial, published in JAMA Psychiatry, show that adults who took mirtazapine—a generic antidepressant—were significantly more likely to reduce their methamphetamine use compared to those given placebo.
This article was originally published on MedicalXpress.com
